PALRX Mutual Fund

PALRX Mutual Fund

NAV$18.93
See how much of PALRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 30, 2026

Net Assets
$44,250.5
Expense Ratio
1.47%
Dividend Yield (Current)
1.46%
Holdings
1,920
Inception Date
Dec 17, 2004
Fund Family
PGIM Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly
SEC 30-Day Yield
PRO

Performance

YTD+4.73%
1 Year+6.39%
3 Year+15.17%
5 Year+6.05%
10 Year+7.84%

Asset Allocation

Stocks: 60.63%
Bonds: 35.64%
Cash: 0.15%
Other: 1.95%
See how much of PALRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
NVDANVIDIA Corp3.87%
AAPLApple Inc3.26%
MSFTMicrosoft Corp2.50%
AMZNAmazon.com Inc1.90%
-NA1.44%
Top 10 Concentration: 18.11%Report Date: Sep 30, 2026
Download all 1920 holdings for PALRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.46%
Frequency
Quarterly
Latest Distribution
$1.97
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PALRX Mutual Fund Overview

PALRX Mutual Fund (PGIM Balanced Fund Class R) is managed by PGIM Investments with $44,250.5 in net assets. PALRX expense ratio is 1.47%, holding 1920 positions across sectors including Information Technology, Financials, Health Care. Inception date: 2004-12-17.

PALRX performance shows a YTD return of 4.73%. The 1-year return is 6.39% and the 5-year return is 6.05%. PALRX dividend yield stands at 1.46%, paid quarterly.

PALRX top holdings include NVIDIA Corp (3.9%), Apple Inc (3.3%), Microsoft Corp (2.5%), Amazon.com Inc (1.9%), NA (1.4%). Go to all PALRX holdings, PALRX sectors, or PALRX dividends.

PALRX can be compared against other funds. Use PALRX overlap to find shared positions, or PALRX vs another fund for a side-by-side view. PALRX alternatives are available via the screener, along with tax-loss harvesting opportunities.